| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-09-23 |
4 |
AS |
$43.29 |
$112,554 |
I/I |
(2,600) |
405,011 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-09-24 |
4 |
AS |
$42.17 |
$110,977 |
I/I |
(2,600) |
402,411 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-07-25 |
4 |
AS |
$15.97 |
$43,283 |
I/I |
(2,700) |
450,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-11-23 |
4 |
AS |
$34.74 |
$97,272 |
I/I |
(2,800) |
392,411 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-07-24 |
4 |
AS |
$16.89 |
$47,421 |
I/I |
(2,800) |
453,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-05-29 |
4 |
AS |
$22.85 |
$67,163 |
I/I |
(2,925) |
293,612 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-05-30 |
4 |
AS |
$22.72 |
$67,926 |
I/I |
(2,925) |
290,687 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-10 |
4 |
AS |
$17.08 |
$51,240 |
I/I |
(3,000) |
479,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-05-30 |
4 |
AS |
$13.44 |
$46,368 |
I/I |
(3,450) |
459,528 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-05-31 |
4 |
AS |
$13.26 |
$45,747 |
I/I |
(3,450) |
456,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
AS |
$18.03 |
$64,908 |
I/I |
(3,600) |
359,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-26 |
4 |
AS |
$17.35 |
$62,460 |
I/I |
(3,600) |
356,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-09-15 |
4 |
AS |
$19.39 |
$69,804 |
I/I |
(3,600) |
422,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-09-16 |
4 |
AS |
$19.32 |
$69,552 |
I/I |
(3,600) |
418,578 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-11-23 |
4 |
AS |
$18.40 |
$67,142 |
I/I |
(3,600) |
384,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-06 |
4 |
AS |
$18.55 |
$66,780 |
I/I |
(3,600) |
381,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-07 |
4 |
AS |
$17.30 |
$62,280 |
I/I |
(3,600) |
377,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-28 |
4 |
AS |
$18.99 |
$68,728 |
I/I |
(3,600) |
482,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-25 |
4 |
AS |
$17.07 |
$62,397 |
I/I |
(3,600) |
471,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-04-26 |
4 |
AS |
$17.78 |
$64,008 |
I/I |
(3,600) |
467,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-06-04 |
4 |
AS |
$41.22 |
$159,911 |
I/I |
(3,800) |
403,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-26 |
4 |
AS |
$39.02 |
$152,221 |
I/I |
(3,900) |
93,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-27 |
4 |
AS |
$36.55 |
$144,211 |
I/I |
(3,900) |
89,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-08-06 |
4 |
AS |
$37.48 |
$146,172 |
I/I |
(3,900) |
85,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-08-07 |
4 |
AS |
$37.35 |
$145,785 |
I/I |
(3,900) |
82,078 |
0 |
- |
|
209 Records found
|
|
Page 4 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
